SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Historical Holders from Q1 2014 to Q3 2025

Symbol
SGMO on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
295M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
62.6M
Holdings value
$42.1M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
111
Number of buys
59
Number of sells
-34
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WASATCH ADVISORS LP 2.1% -62% $4.17M -$3.66M 6.19M -46.8% Wasatch Advisors LP 30 Sep 2025

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 62.6M $42.1M -$4.09M $0.67 111
2025 Q2 73.2M $39.6M -$1.37M $0.54 110
2025 Q1 52.6M $34.5M -$6.97M $0.66 118
2024 Q4 61.5M $62.8M +$5.84M $1.02 125
2024 Q3 55.9M $48.4M -$13.2M $0.87 100
2024 Q2 86.9M $31.1M -$5.51M $0.36 126
2024 Q1 100M $67.3M +$9.59M $0.67 125
2023 Q4 87M $47.2M -$9.27M $0.54 129
2023 Q3 102M $61.3M -$4.25M $0.60 131
2023 Q2 106M $137M -$10.8M $1.30 149
2023 Q1 112M $198M +$12M $1.76 178
2022 Q4 104M $326M +$18.1M $3.14 179
2022 Q3 97.4M $477M +$38.5M $4.90 189
2022 Q2 89.7M $371M +$44.1M $4.14 174
2022 Q1 80M $465M +$13.3M $5.81 184
2021 Q4 76.9M $577M +$14.7M $7.50 178
2021 Q3 75.2M $679M -$11.3M $9.01 182
2021 Q2 76.2M $912M -$39.6M $11.97 189
2021 Q1 79.4M $994M +$8.74M $12.53 189
2020 Q4 78.3M $1.22B -$2.89M $15.61 215
2020 Q3 81.6M $772M +$39.7M $9.45 203
2020 Q2 77.1M $690M +$38.4M $8.96 197
2020 Q1 74M $471M -$44.2M $6.37 175
2019 Q4 78.5M $657M -$35.5M $8.37 187
2019 Q3 82.1M $744M +$18.2M $9.05 178
2019 Q2 79.9M $860M +$188M $10.77 178
2019 Q1 65.9M $629M +$8.49M $9.54 178
2018 Q4 64M $734M -$24.5M $11.48 189
2018 Q3 64.6M $1.1B +$6.28M $16.95 214
2018 Q2 64.7M $919M +$102M $14.20 206
2018 Q1 57.2M $1.09B +$32.1M $19.00 205
2017 Q4 55.6M $911M +$36.6M $16.40 167
2017 Q3 54.7M $820M +$37.4M $15.00 147
2017 Q2 53M $467M +$101M $8.80 143
2017 Q1 41.9M $218M +$36.4M $5.20 115
2016 Q4 41.3M $126M -$12M $3.05 120
2016 Q3 44M $203M -$12.2M $4.63 121
2016 Q2 46.2M $268M -$15.6M $5.79 136
2016 Q1 48.7M $292M -$4.02M $6.05 142
2015 Q4 49.1M $448M -$26.3M $9.13 139
2015 Q3 52.7M $297M -$28.2M $5.64 140
2015 Q2 50.6M $561M -$37.8M $11.09 156
2015 Q1 52.6M $825M +$55.2M $15.68 167
2014 Q4 49.2M $747M +$7.3M $15.21 157
2014 Q3 48.8M $527M -$9.06M $10.79 157
2014 Q2 48.9M $746M -$18.4M $15.27 154
2014 Q1 48.2M $871M +$52.8M $18.08 144